Standard BioTools Inc. Files Proxy Materials

TL;DR

Standard BioTools filed proxy docs, no fee. Shareholders vote soon.

AI Summary

Standard BioTools Inc. (formerly Fluidigm Corp) filed a Definitive Additional Materials proxy statement on June 3, 2024. This filing is related to the company's proxy materials and does not require a filing fee. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

Proxy statements are crucial for shareholders to understand company proposals and exercise their voting rights, impacting corporate governance and strategic decisions.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not contain information that inherently increases risk for the company or its investors.

Key Players & Entities

• STANDARD BIOTOOLS INC. (company) — Registrant
• FLUIDIGM CORP (company) — Former Company Name
• 0001162194 (company) — Central Index Key
• 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO, CA 94080 (company) — Business Address
• 6502666000 (company) — Business Phone

FAQ

Filing Documents

• ef20030522_defa14a.htm (DEFA14A) — 25KB
• image00001.jpg (GRAPHIC) — 4KB
• proxycard1.jpg (GRAPHIC) — 481KB
• proxycard2.jpg (GRAPHIC) — 672KB
• 0001140361-24-028636.txt ( ) — 1619KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Under 240.14a-12 Standard BioTools Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 2 Tower Place, Suite 2000 South San Francisco, California 94080 (650) 266-6000 SUPPLEMENT NO. 1 TO THE PROXY STATEMENT FOR THE STANDARD BIOTOOLS INC. ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 27, 2024 This Supplement No. 1 (this "Supplement"), dated June 3, 2024, supplements the definitive proxy statement on Schedule 14A (the "Proxy Statement") filed by Standard BioTools Inc., a Delaware corporation (referred to herein as "we", "us", "our" or the "Company") with the U.S. Securities and Exchange Commission (the "SEC") on May 21, 2024, in connection with the solicitation by the Company's Board of Directors (the "Board") of proxies to be voted at the Company's 2024 Annual Meeting of Stockholders, or any adjournment or postponement thereof (the "Annual Meeting"). THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT, WHICH CONTAINS IMPORTANT ADDITIONAL INFORMATION. Except as to the matters specifically discussed herein, this Supplement does not otherwise modify or update any information or disclosure contained in the Proxy Statement. Capitalized terms used but not otherwise defined in this Supplement shall have the meanings assigned to such terms in the Proxy Statement. As described in the Proxy Statement, Madryn previously notified the Company that it intended to (i) nominate two nominees (the "Madryn Nominees") to stand for election as directors of the Company at the Annual Meeting in opposition to the nominees recommended by the Board and (ii) submit for stockholder consideration at the Annual Meeting a non-binding proposal urging the Board to take all steps necessary to declassify the Board (the "Declassification Proposal"). On May 31, 2024, Madryn notified the Company that it has irrevocably withdrawn its notice with respect to the Madryn Nominees and the Declassification Proposal and that Madryn no longer intends to solicit the holders of shares of the Company's common stock representing at least 67% of the total voting power of shares entitled to vote on the election of the Company's directors (the minimum solicitation required under Rule 14a-19 under the Securities Exchange Act of 1934, as amended) in support of the Madryn Nominees at the Annual Meeting. Because Madryn has withdrawn the Madryn Nominees and the Declassification Proposal, the election of the Madryn Nominees and the Declassification Proposal will not be brought before the Annual Meeting. In light of the development described above, this Supplement includes (i) additional information you should read in conjunction with the Proxy Statement and (ii) a new WHITE proxy card that removes the Madryn Nominees and the Declassification Proposal. As a result of Madryn's withdrawal of its notice with respect to the Madryn Nominees and the Declassification Proposal, any vote cast in favor of the Madryn Nominees or Declassification Proposal on the previous WHITE universal proxy card will not be recognized, tabulated at the Annual Meeting or have any legal effect. Stockholders who submitted the previous WHITE universal proxy card voting " FOR " the Madryn Nominees or Declassification Proposals can revoke that proxy by completing, signing, dating and promptly returning the new WHITE proxy card in the postage-paid envelope provided or by voting via the Internet or telephone by following the instructions on the new WHITE proxy card. Any votes on the Company's previous WHITE universal proxy card " FOR " the Company's nominees with respect to Proposal 1 or " FOR ", " AGAINST " or " ABSTAIN " on Proposals 2, 3 or 4 remain valid and will be tabulated at the Annual Meeting. Stockholders who submitted the Company's previous WHITE universal proxy card voting "FOR" the Company's nominees with respect to Proposal 1 or "FOR", "AGAINST" or "ABSTAIN" on Proposals 2, 3 or 4 do not need to take any further action. If your shares are held in "street name" through an intermediary such as a broker, bank, trustee or other nominee, you will receive voting instructions from your broker, bank, trustee or other nominee. You must follow these instructions in order for your shares to be voted on

View Full Filing

View this DEFA14A filing on SEC EDGAR